SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-24-003777
Filing Date
2024-05-22
Accepted
2024-05-22 16:11:07
Documents
16
Period of Report
2024-05-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K sunshine_8k.htm   iXBRL 8-K 28124
2 PRESS RELEASE sunshine_ex9901.htm EX-99.1 13739
7 GRAPHIC image_001.jpg GRAPHIC 6358
  Complete submission text file 0001683168-24-003777.txt   271367

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE sbfm-20240521.xsd EX-101.SCH 3553
4 XBRL DEFINITION FILE sbfm-20240521_def.xml EX-101.DEF 26585
5 XBRL LABEL FILE sbfm-20240521_lab.xml EX-101.LAB 36550
6 XBRL PRESENTATION FILE sbfm-20240521_pre.xml EX-101.PRE 25209
19 EXTRACTED XBRL INSTANCE DOCUMENT sunshine_8k_htm.xml XML 5523
Mailing Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR NEW YORK NY 10036
Business Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR NEW YORK NY 10036 332-216-1147
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41282 | Film No.: 24973346
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)